FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,543,342 | -44.3% | 3,670,516 | 0.0% | 3.52% | -34.0% |
| Q2 2023 | $17,141,310 | +23.9% | 3,670,516 | 0.0% | 5.32% | +18.2% |
| Q1 2023 | $13,837,845 | +119583.8% | 3,670,516 | 0.0% | 4.50% | +33.8% |
| Q4 2022 | $11,562 | -99.9% | 3,670,516 | 0.0% | 3.36% | +3.5% |
| Q3 2022 | $11,048,000 | +20.9% | 3,670,516 | 0.0% | 3.25% | +39.2% |
| Q2 2022 | $9,140,000 | -68.0% | 3,670,516 | 0.0% | 2.34% | -56.7% |
| Q1 2022 | $28,520,000 | +86.3% | 3,670,516 | 0.0% | 5.39% | +209.5% |
| Q4 2021 | $15,306,000 | -47.3% | 3,670,516 | 0.0% | 1.74% | -31.7% |
| Q3 2021 | $29,070,000 | – | 3,670,516 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $11,562 | 3.36% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $9,285,598 | 3.10% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4,917,100 | 2.14% |
| Sio Capital Management, LLC | 260,448 | $820,411 | 0.30% |
| BRAIDWELL LP | 2,000,000 | $6,300,000 | 0.21% |
| Orbimed Advisors | 3,224,770 | $10,158,026 | 0.19% |
| TPG GP A, LLC | 2,551,794 | $8,038,151 | 0.16% |
| Artal Group S.A. | 750,000 | $2,363 | 0.13% |
| RA Capital Management | 659,992 | $2,078,975 | 0.04% |
| SECTORAL ASSET MANAGEMENT INC | 57,297 | $180,486 | 0.04% |